Who Paid My Doc
Yan Kalika
Dentist, Orthodontics and Dentofacial Orthopedics San Francisco, CA Doctor of Dentistry
NPI 1427251644 CMS profile 574668
3412 Geary Blvd, San Francisco, CA 94118
General payments
$888,708
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Yan Kalika of San Francisco, CA is reported in the CMS Open Payments database as having received $888,708 across 374 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 99th percentile of Dentist, Orthodontics and Dentofacial Orthopedics profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
7 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $192,532 | 68 | |
| 2024 | General | $195,733 | 99 | |
| 2023 | General | $262,213 | 76 | |
| 2022 | General | $174,418 | 71 | |
| 2021 | General | $3,029 | 26 | |
| 2020 | General | $59,281 | 13 | |
| 2019 | General | $1,501 | 21 |
Beside peers
- Yan Kalika
- Dentist, Orthodontics and Dentofacial Orthopedics median
- Middle half of Dentist, Orthodontics and Dentofacial Orthopedics
- National median
In program year 2025, general payments to Yan Kalika were reported at $192,532. Among 7,792 Dentist, Orthodontics and Dentofacial Orthopedics profiles paid that year, the median was $146 and the middle half received between $52 and $382.
Show as a table
| Year | Yan Kalika | Dentist, Orthodontics and Dentofacial Orthopedics median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $1,501 | $100 | $36–$271 | $163 |
| 2020 | $59,281 | $111 | $63–$221 | $114 |
| 2021 | $3,029 | $110 | $46–$231 | $132 |
| 2022 | $174,418 | $122 | $44–$312 | $149 |
| 2023 | $262,213 | $145 | $51–$392 | $160 |
| 2024 | $195,733 | $126 | $50–$309 | $164 |
| 2025 | $192,532 | $146 | $52–$382 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Records
374 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Dentist, Orthodontics and Dentofacial Orthopedics in California
Norman Jacobson
Dentist, Orthodontics and Dentofacial Orthopedics · Salinas, CA
Michael Florman
Dentist, Orthodontics and Dentofacial Orthopedics · Santa Monica, CA
David Boschken
Dentist, Orthodontics and Dentofacial Orthopedics · San Jose, CA
Eric Kuo
Dentist, Orthodontics and Dentofacial Orthopedics · San Francisco, CA
Ronald Roncone
Dentist, Orthodontics and Dentofacial Orthopedics · Vista, CA
Robert Boyd
Dentist, Orthodontics and Dentofacial Orthopedics · San Francisco, CA
Related records
Dentist, Orthodontics and Dentofacial Orthopedics in California
Practitioners in the same specialty and state, ranked by reported value.
All Dentist, Orthodontics and Dentofacial Orthopedics
Everyone recorded under this specialty, nationwide.
Doctors in California
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.